Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $25,875,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Paul Vigano sold 2,250,000 shares of the business’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $11.50, for a total transaction of $25,875,000.00. Following the completion of the transaction, the insider owned 12,315,892 shares of the company’s stock, valued at approximately $141,632,758. This represents a 15.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Aveanna Healthcare Price Performance

Shares of Aveanna Healthcare stock traded up $0.54 during trading hours on Monday, reaching $13.70. The stock had a trading volume of 5,371,630 shares, compared to its average volume of 1,804,159. The stock’s 50 day moving average is $9.58 and its 200 day moving average is $7.92. The firm has a market capitalization of $2.99 billion, a PE ratio of 11.14, a PEG ratio of 0.92 and a beta of 1.90. Aveanna Healthcare Holdings Inc. has a twelve month low of $5.93 and a twelve month high of $13.98. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The firm had revenue of $670.48 million for the quarter, compared to analysts’ expectations of $638.61 million. Equities analysts expect that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current fiscal year.

Trending Headlines about Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Royal Bank of Canada raised its price target for Aveanna Healthcare from $10 to $16 and upgraded the stock to “outperform.” The new target implies additional upside from recent trading levels, providing a bullish signal for AVAH. Benzinga analyst price-target report
• Neutral Sentiment: Truist Financial increased its price target from $11 to $15 but maintained a “hold” rating. The higher valuation suggests improved expectations, while the unchanged rating indicates the firm does not see a compelling reason to become more bullish after the stock’s recent advance. Benzinga analyst price-target report
• Negative Sentiment: Several insiders sold a combined 320,000 shares at an average price of $11.50, generating approximately $3.68 million. CEO Jeff Shaner sold 90,000 shares, director Rodney D. Windley sold 180,000, and insider Edwin C. Reisz sold 50,000. Each retained a substantial stake, but the coordinated sales—particularly Windley’s roughly 8% position reduction—could raise concerns about insider confidence or add near-term selling pressure. CEO insider sale filing Director insider sale filing Insider sale filing

Institutional Investors Weigh In On Aveanna Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. acquired a new stake in shares of Aveanna Healthcare in the second quarter valued at approximately $63,504,000. Vanguard Group Inc. grew its holdings in Aveanna Healthcare by 38.0% in the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after buying an additional 1,535,351 shares in the last quarter. Millennium Management LLC increased its stake in shares of Aveanna Healthcare by 1,007.1% in the 4th quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after acquiring an additional 1,014,030 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Aveanna Healthcare during the 2nd quarter valued at about $7,881,000. Finally, Nuveen LLC grew its holdings in shares of Aveanna Healthcare by 135.9% in the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after purchasing an additional 905,316 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analyst Ratings Changes

AVAH has been the topic of a number of recent analyst reports. Truist Financial increased their target price on Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a research report on Monday. BMO Capital Markets upped their price objective on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. UBS Group raised their price target on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a research note on Friday, August 14th. Finally, Royal Bank Of Canada boosted their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Aveanna Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $12.89.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.